{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:32:01Z","timestamp":1781796721648,"version":"3.54.5"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.02577","type":"journal-article","created":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T04:56:00Z","timestamp":1573102560000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Interleukin-35 Regulates Immune Microenvironment of Autoimmune Hepatitis Through Inducing the Expansion of Myeloid-Derived Suppressor Cells"],"prefix":"10.3389","volume":"10","author":[{"given":"Min","family":"Lian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanshen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qixia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengliang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,11,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1053\/jhep.2002.34944","article-title":"American Association for the Study of Liver D. Diagnosis and treatment of autoimmune hepatitis","volume":"36","author":"Czaja","year":"2002","journal-title":"Hepatology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJMra050408","article-title":"Autoimmune hepatitis","volume":"354","author":"Krawitt","year":"2006","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1600-065X.2008.00704.x","article-title":"Interleukin-35: odd one out or part of the family?","volume":"226","author":"Collison","year":"2008","journal-title":"Immunol Rev"},{"key":"B4","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nature06306","article-title":"The inhibitory cytokine IL-35 contributes to regulatory T-cell function","volume":"450","author":"Collison","year":"2007","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.molimm.2012.03.025","article-title":"Distinct subunit pairing criteria within the heterodimeric IL-12 cytokine family","volume":"51","author":"Jones","year":"2012","journal-title":"Mol Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"12041","DOI":"10.1073\/pnas.94.22.12041","article-title":"Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin","volume":"94","author":"Devergne","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"B7","doi-asserted-by":"publisher","first-page":"6898","DOI":"10.4049\/jimmunol.181.10.6898","article-title":"Human CD4+ CD25+ Foxp3+ regulatory T cells do not constitutively express IL-35","volume":"181","author":"Bardel","year":"2008","journal-title":"J Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nri1001","article-title":"Interleukin-12 and the regulation of innate resistance and adaptive immunity","volume":"3","author":"Trinchieri","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/ni.2227","article-title":"The composition and signaling of the IL-35 receptor are unconventional","volume":"13","author":"Collison","year":"2012","journal-title":"Nat Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1002\/eji.200737810","article-title":"IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells","volume":"37","author":"Niedbala","year":"2007","journal-title":"Eur J Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1053\/j.gastro.2011.07.040","article-title":"Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis","volume":"141","author":"Wirtz","year":"2011","journal-title":"Gastroenterology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/gt.2011.32","article-title":"Use of cytokine immunotherapy to block CNS demyelination induced by a recombinant HSV-1 expressing IL-2","volume":"18","author":"Zandian","year":"2011","journal-title":"Gene Ther"},{"key":"B13","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.intimp.2011.01.003","article-title":"Myeloid derived suppressor cells in human diseases","volume":"11","author":"Greten","year":"2011","journal-title":"Int Immunopharmacol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"12150","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat Commun"},{"key":"B15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.semcancer.2005.07.005","article-title":"Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression","volume":"16","author":"Serafini","year":"2006","journal-title":"Semin Cancer Biol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"5243","DOI":"10.1158\/1078-0432.CCR-07-0182","article-title":"Pathways mediating the expansion and immunosuppressive activity of myeloid-derived suppressor cells and their relevance to cancer therapy","volume":"13","author":"Talmadge","year":"2007","journal-title":"Clin Cancer Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/hep.29418","article-title":"The functional characteristics CCNI modulation of myeloid- derived suppressor cells in liver inflammation","volume":"67","author":"Zhang","year":"2018","journal-title":"Hepatology."},{"key":"B19","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1016\/S0140-6736(10)61965-4","article-title":"Primary biliary cirrhosis","volume":"377","author":"Selmi","year":"2011","journal-title":"Lancet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: Management of chronic hepatitis B virus infection","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/ajg.2012.128","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"107","author":"Chalasani","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"B23","first-page":"106","article-title":"Primary biliary cirrhosis: diagnosis, pathology and pathogenesis","volume":"59","author":"Scheuer","year":"1983","journal-title":"Postgrad Med J"},{"key":"B24","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.jaci.2014.08.040","article-title":"Subsets of airway myeloid-derived regulatory cells distinguish mild asthma from chronic obstructive pulmonary disease","volume":"135","author":"Deshane","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"5693","DOI":"10.4049\/jimmunol.0900092","article-title":"Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells","volume":"182","author":"Corzo","year":"2009","journal-title":"J Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S1074-7613(02)00324-2","article-title":"IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells","volume":"16","author":"Pflanz","year":"2002","journal-title":"Immunity"},{"key":"B27","doi-asserted-by":"publisher","first-page":"5514","DOI":"10.1158\/0008-5472.CAN-08-4625","article-title":"The liver is a site for tumor-induced myeloid-derived suppressor cell accumulation and immunosuppression","volume":"69","author":"Ilkovitch","year":"2009","journal-title":"Cancer Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/cei.12639","article-title":"Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin. (IL)-35 in Murphy Roths Large (MRL)\/lpr mice","volume":"181","author":"Cai","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3389\/fimmu.2014.00017","article-title":"Thymus-derived, peripherally derived, and in vitro-induced T regulatory cells","volume":"5","author":"Elkord","year":"2014","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"7144","DOI":"10.4049\/jimmunol.0902739","article-title":"IL-35 stimulation of CD39+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10","volume":"184","author":"Kochetkova","year":"2010","journal-title":"J Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jaut.2014.02.010","article-title":"The critical role of myeloid-derived suppressor cells and FXR activation in immune-mediated liver injury","volume":"53","author":"Zhang","year":"2014","journal-title":"J Autoimmun"},{"key":"B32","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.4049\/jimmunol.1100106","article-title":"Increased Th17 and regulatory T cell responses in EBV-induced gene 3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis","volume":"188","author":"Liu","year":"2012","journal-title":"J Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/S0002-9440(10)63023-4","article-title":"Expression of Epstein-Barr virus-induced gene 3, an interleukin-12 p40-related molecule, throughout human pregnancy: involvement of syncytiotrophoblasts and extravillous trophoblasts","volume":"159","author":"Devergne","year":"2001","journal-title":"Am J Pathol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"5308","DOI":"10.1093\/nar\/gki836","article-title":"NF-kappaB controls the global pro-inflammatory response in endothelial cells: evidence for the regulation of a pro-atherogenic program","volume":"33","author":"Kempe","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/path.1995","article-title":"Variable expression of Epstein-Barr virus-induced gene 3 during normal B-cell differentiation and among B-cell lymphomas","volume":"209","author":"Larousserie","year":"2006","journal-title":"J Pathol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/path.1508","article-title":"Expression of IL-27 in human Th1-associated granulomatous diseases","volume":"202","author":"Larousserie","year":"2004","journal-title":"J Pathol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/path.1217","article-title":"Frequent expression of the Epstein-Barr virus (EBV)-induced gene, EBI3, an IL-12 p40-related cytokine, in Hodgkin and Reed-Sternberg cells","volume":"198","author":"Niedobitek","year":"2002","journal-title":"J Pathol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e33628","DOI":"10.1371\/journal.pone.0033628","article-title":"IL-35 is a novel responsive anti-inflammatory cytokine\u2013a new system of categorizing anti-inflammatory cytokines","volume":"7","author":"Li","year":"2012","journal-title":"PLoS ONE."},{"key":"B39","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1159\/000369141","article-title":"Upregulation of interleukin-35 subunits in regulatory T cells in a murine model of allergic rhinitis","volume":"76","author":"Shen","year":"2014","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"B40","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1089\/jir.2012.0086","article-title":"Interleukin-35: the future of hyperimmune-related diseases?","volume":"33","author":"Ye","year":"2013","journal-title":"J Interferon Cytokine Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.1182\/blood-2007-07-099226","article-title":"Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity","volume":"111","author":"Movahedi","year":"2008","journal-title":"Blood"},{"key":"B42","doi-asserted-by":"publisher","first-page":"5791","DOI":"10.4049\/jimmunol.181.8.5791","article-title":"Subsets of myeloid-derived suppressor cells in tumor-bearing mice","volume":"181","author":"Youn","year":"2008","journal-title":"J Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02577\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T04:56:02Z","timestamp":1573102562000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02577\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,7]]},"references-count":42,"alternative-id":["10.3389\/fimmu.2019.02577"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.02577","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,7]]},"article-number":"2577"}}